Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions

被引：0
|
作者：
Said Benahmed
Marie Christine Picot
Dominique Hillaire-Buys
Jean Pierre Blayac
Pierre Dujols
Pascal Demoly
机构：
[1] INSERM U454—IFR3,Exploration des Allergies
[2] Hôpital Arnaud de Villeneuve,Maladies Respiratoires
[3] Hôpital Arnaud de Villeneuve,Département d’Information Médicale
[4] Centre Régional de Pharmacovigilance du Languedoc-Roussillon,Pharmacologie Médicale
[5] Hôpital Lapeyronie,undefined
来源：
European Journal of Clinical Pharmacology | 2005年 / 61卷
关键词：
Algorithms; Causality assessment; Drug allergy; Hypersensitivity; Pharmacovigilance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：537 / 541
页数：4
相关论文
共 50 条
  • [1] Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions
    Benahmed, S
    Picot, MC
    Hillaire-Buys, D
    Blayac, JP
    Dujols, P
    Demoly, P
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 61 (07) : 537 - 541
  • [2] Accuracy of a pharmacovigilance algorithm in diagnosing drug hypersensitivity reactions
    Benahmed, S
    Picot, MC
    Dumas, F
    Demoly, P
    ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (13) : 1500 - 1505
  • [3] Algorithms in Drug Safety and Pharmacovigilance Presentation of the scientific and theoretical bases for the assessment of adverse reactions in a pharmacovigilance department
    Treier, S
    Fahlbusch, T
    Schmeidl, R
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S98 - S98
  • [4] Drug Hypersensitivity Reactions
    Wilkerson, R. Gentry
    EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2022, 40 (01) : 39 - 55
  • [5] Drug Hypersensitivity Reactions
    Dykewicz, Mark S.
    Lam, Jason K.
    MEDICAL CLINICS OF NORTH AMERICA, 2020, 104 (01) : 109 - +
  • [6] Hypersensitivity drug reactions
    Thong, Bernard Y.
    Blanca, Miguel
    CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 14 (04) : 269 - 270
  • [7] Drug Hypersensitivity Reactions
    Wilkerson, R. Gentry
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (03) : 473 - 489
  • [8] Insulin glargine and hypersensitivity reactions as an example of biosimilars pharmacovigilance
    Ali, Ayad K.
    Bohm, Martin S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 22 - 22
  • [9] Pharmacovigilance and the reporting of adverse drug reactions
    Terblanche, Antoinette
    SA PHARMACEUTICAL JOURNAL, 2018, 85 (06) : 65 - 68
  • [10] Pharmacovigilance and Reporting Adverse Drug Reactions
    Isa, N. M.
    MEDICINE AND HEALTH-KUALA LUMPUR, 2014, 9 (02): : 92 - 102
12345